US2985657A
(en)
*
|
1959-10-12 |
1961-05-23 |
Paul A J Janssen |
1-(aroylalkyl)-4-heterocyclylpiperazines
|
US3830924A
(en)
*
|
1966-12-23 |
1974-08-20 |
American Cyanamid Co |
Substituted nitroimidazolyl-thiadiazoles as growth promoting agents
|
DE2341925A1
(de)
|
1973-08-20 |
1975-03-06 |
Thomae Gmbh Dr K |
Neue pyrimidinderivate und verfahren zu ihrer herstellung
|
AT340933B
(de)
*
|
1973-08-20 |
1978-01-10 |
Thomae Gmbh Dr K |
Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze
|
DE2516040C2
(de)
|
1974-06-10 |
1984-12-20 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
|
DE2427943C2
(de)
|
1974-06-10 |
1984-08-02 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
|
NL171985C
(nl)
|
1976-02-10 |
1983-06-16 |
Rhone Poulenc Ind |
Werkwijze voor het bereiden van preparaten met werking tegen schistosomiasis, de aldus verkregen gevormde preparaten en werkwijze voor het bereiden van 1,2-dithioolverbindingen.
|
DE2965377D1
(en)
|
1978-10-02 |
1983-06-16 |
Lepetit Spa |
6-amino substituted n-pyrrolyl-3-pyridazine amines, their preparation, and pharmaceutically antihypertensive compositions containing them
|
US4247551A
(en)
*
|
1979-09-17 |
1981-01-27 |
Gruppo Lepetit S.P.A. |
N-Pyrrolyl-pyridazineamines and their use as antihypertensive agents
|
FI70411C
(fi)
|
1980-12-29 |
1986-09-19 |
Pfizer |
Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat
|
US4439606A
(en)
*
|
1982-05-06 |
1984-03-27 |
American Cyanamid Company |
Antiatherosclerotic 1-piperazinecarbonyl compounds
|
CH655103A5
(de)
|
1983-03-11 |
1986-03-27 |
Sandoz Ag |
Azolderivate, verfahren zu ihrer herstellung und ihre verwendung.
|
US5001125A
(en)
|
1984-03-26 |
1991-03-19 |
Janssen Pharmaceutica N.V. |
Anti-virally active pyridazinamines
|
DE3685840D1
(de)
|
1985-04-30 |
1992-08-06 |
Dresden Arzneimittel |
3-cyan-pyridine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
|
ES8802151A1
(es)
|
1985-07-31 |
1988-04-01 |
Janssen Pharmaceutica Nv |
Un procedimiento para la preparacion de nuevos piridazinaminas.
|
DE3536030A1
(de)
|
1985-10-09 |
1987-04-09 |
Thomae Gmbh Dr K |
Verwendung von benzimidazolen zur behandlung der migraene
|
WO1988007527A1
(en)
|
1987-04-03 |
1988-10-06 |
The Upjohn Company |
Amino-9,10-secosteroids
|
CA1338012C
(en)
|
1987-04-27 |
1996-01-30 |
John Michael Mccall |
Pharmaceutically active amines
|
NZ225045A
(en)
|
1987-07-01 |
1990-06-26 |
Janssen Pharmaceutica Nv |
Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent
|
MY104343A
(en)
|
1987-11-23 |
1994-03-31 |
Janssen Pharmaceutica Nv |
Novel pyridizinamine deravatives
|
DE3827599A1
(de)
*
|
1988-08-13 |
1990-02-15 |
Hoechst Ag |
Verwendung von optisch aktiven tetrahydrofuran-2-carbonsaeureestern als dotierstoffe in fluessigkristallmischungen, diese enthaltende fluessigkristallmischungen und neue optisch aktive tetrahydrofuran-2-carbonsaeureester
|
WO1991009849A1
(en)
|
1989-12-28 |
1991-07-11 |
The Upjohn Company |
Diaromatic substituted anti-aids compounds
|
EP0507863A4
(en)
|
1989-12-28 |
1993-07-07 |
Virginia Commonwealth University |
Sigma receptor ligands and the use thereof
|
IL96891A0
(en)
|
1990-01-17 |
1992-03-29 |
Merck Sharp & Dohme |
Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
|
US5166147A
(en)
*
|
1990-07-09 |
1992-11-24 |
The Du Pont Merck Pharmaceutical Company |
4-heteroaryl-and 4-aryl-1,4-dihydropyridine, derivatives with calcium agonist and alpha1 -antagonist activity
|
EP0471201A1
(de)
*
|
1990-07-21 |
1992-02-19 |
Hoechst Aktiengesellschaft |
Neue Oxazolidinon-Derivate und ihre Verwendung als Dotierstoffe in Flüssigkristallmischungen
|
DE4031000A1
(de)
|
1990-10-01 |
1992-04-09 |
Hoechst Ag |
4- oder 5-substituierte pyridin-2-carbonsaeuren, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
|
IT1245712B
(it)
|
1991-04-09 |
1994-10-14 |
Boehringer Mannheim Italia |
Ammine eterocicliche utili terapia dell'asma e dell'infiammazione delle vie aeree
|
EP0520292A1
(de)
*
|
1991-06-19 |
1992-12-30 |
Hoechst Aktiengesellschaft |
Chirale Azetidinon-Derivate und ihre Verwendung als Dotierstoffe in Flüssigkristallmischungen
|
AU676993B2
(en)
|
1991-06-27 |
1997-04-10 |
Virginia Commonwealth University |
Sigma receptor ligands and the use thereof
|
WO1993001181A1
(en)
|
1991-07-03 |
1993-01-21 |
The Upjohn Company |
Substituted indoles as anti-aids pharmaceuticals
|
EP0524146A1
(de)
|
1991-07-19 |
1993-01-20 |
Ciba-Geigy Ag |
Aminosubstituierte Piperazinderivate
|
DE4124942A1
(de)
*
|
1991-07-27 |
1993-01-28 |
Thomae Gmbh Dr K |
5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
GB9117639D0
(en)
|
1991-08-15 |
1991-10-02 |
Ici Plc |
Therapeutic compounds
|
JPH05255089A
(ja)
|
1991-12-18 |
1993-10-05 |
Sanwa Kagaku Kenkyusho Co Ltd |
抗ウイルス剤
|
JPH05345780A
(ja)
*
|
1991-12-24 |
1993-12-27 |
Kumiai Chem Ind Co Ltd |
ピリミジンまたはトリアジン誘導体及び除草剤
|
AU3351293A
(en)
|
1992-01-21 |
1993-08-03 |
Glaxo Group Limited |
Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
|
WO1993018016A1
(en)
|
1992-03-11 |
1993-09-16 |
E.I. Du Pont De Nemours And Company |
Fungicidal oxazolidinones
|
HU209678B
(en)
|
1992-06-09 |
1994-10-28 |
Richter Gedeon Vegyeszet |
Process for producing biologically active eburnamenin-14-carbonyl-amino derivatives and pharmaceutical compositions containing them
|
IT1255704B
(it)
|
1992-09-30 |
1995-11-10 |
Boehringer Mannheim Italia |
Ammine eterocicliche utili nella terapia dell'asma e dell'infiammazione delle vie aeree
|
DE4236106A1
(de)
*
|
1992-10-26 |
1994-04-28 |
Hoechst Ag |
Azaaromatische Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung in flüssigkristallinen Mischungen
|
US5494908A
(en)
|
1992-11-23 |
1996-02-27 |
Hoechst-Roussel Pharmaceutical Incorporated |
Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds
|
US5380726A
(en)
|
1993-01-15 |
1995-01-10 |
Ciba-Geigy Corporation |
Substituted dialkylthio ethers
|
DE4302051A1
(de)
|
1993-01-26 |
1994-07-28 |
Thomae Gmbh Dr K |
5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
|
FR2713641B1
(fr)
*
|
1993-12-09 |
1997-04-11 |
Egyt Gyogyszervegyeszeti Gyar |
Dérivés de l'épi-épibatidine.
|
US5547605A
(en)
*
|
1993-12-15 |
1996-08-20 |
Hoechst Aktiengesellschaft |
2-Aryloxytetrafluoropropionic esters, process for their preparation, and their use in liquid-crystalline mixtures
|
DE4343286A1
(de)
|
1993-12-17 |
1995-06-22 |
Hoechst Ag |
Heteroaromatische Verbindungen und ihre Verwendung in flüssigkristallinen Mischungen
|
DE19502178A1
(de)
*
|
1994-01-27 |
1995-08-03 |
Hoechst Ag |
Thiadiazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Vorprodukte zur Herstellung von Flüssigkristallen
|
US5464788A
(en)
|
1994-03-24 |
1995-11-07 |
Merck & Co., Inc. |
Tocolytic oxytocin receptor antagonists
|
DE4423044A1
(de)
|
1994-07-01 |
1996-01-04 |
Hoechst Ag |
1-(3-Alkyloxiran-2-yl)alkylester mesogener Carbonsäuren und ihre Verwendung in flüssigkristallinen Mischungen
|
US5637592A
(en)
*
|
1994-07-12 |
1997-06-10 |
Janssen Pharmaceutica N.V. |
Acyl derivatives of azolones
|
US5607932A
(en)
|
1994-07-12 |
1997-03-04 |
Janssen Pharmaceutica N.V. |
Heterocyclic derivatives of azolones
|
US5571811A
(en)
*
|
1994-07-12 |
1996-11-05 |
Janssen Pharmaceutica N.V. |
Sulfonamide derivatives of azolones
|
DK0788511T3
(da)
|
1994-10-07 |
2003-03-31 |
Fujisawa Pharmaceutical Co |
Cykliske hexapeptider med antibiotisk aktivitet
|
US5702637A
(en)
|
1995-04-19 |
1997-12-30 |
Minnesota Mining And Manufacturing Company |
Liquid crystal compounds having a chiral fluorinated terminal portion
|
US5668148A
(en)
*
|
1995-04-20 |
1997-09-16 |
Merck & Co., Inc. |
Alpha1a adrenergic receptor antagonists
|
DE19517025A1
(de)
*
|
1995-05-10 |
1996-11-14 |
Hoechst Ag |
Trifluortetrahydroisochinolin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen
|
DE19517060A1
(de)
*
|
1995-05-10 |
1996-11-14 |
Hoechst Ag |
1-Fluorisochinolinderivate und ihre Verwendung in flüssigkristallinen Mischungen
|
DE19517038A1
(de)
*
|
1995-05-10 |
1996-11-14 |
Hoechst Ag |
1,8-Difluorisochinolinderivate und ihre Verwendung in flüssigkristallinen Mischungen
|
DE19517051A1
(de)
*
|
1995-05-10 |
1996-11-14 |
Hoechst Ag |
1-Fluor-6,7-dihydro-5H-isochinolin-8-on-Derivate und ihre Verwendung in flüssigkristallinen Mischungen
|
DE19517056A1
(de)
*
|
1995-05-10 |
1996-11-14 |
Hoechst Ag |
1-Fluor-5,6,7,8-tetrahydroisochinolin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen
|
TW357143B
(en)
|
1995-07-07 |
1999-05-01 |
Novartis Ag |
Benzo[g]quinoline derivatives
|
JPH11513382A
(ja)
*
|
1995-10-20 |
1999-11-16 |
ドクトル カルル トーマエ ゲゼルシャフト ミット ベシュレンクテル ハフツング |
5員複素環化合物、これらの化合物を含む医薬品、それらの使用及びそれらの調製方法
|
ZA969622B
(en)
|
1995-12-13 |
1998-05-15 |
Upjohn Co |
Oxazolidinone antibacterial agents having a six-membered heteroaromatic ring.
|
IL124461A
(en)
*
|
1996-01-15 |
2000-07-26 |
Janssen Pharmaceutica Nv |
Angiogenesis inhibiting 3-(1,2,4-thiadiazol-5-yl)piperazine pyridazine derivatives their preparation and pharmaceutical compositions containing them
|
DE19614204A1
(de)
*
|
1996-04-10 |
1997-10-16 |
Thomae Gmbh Dr K |
Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
JPH107572A
(ja)
|
1996-06-17 |
1998-01-13 |
Sumitomo Pharmaceut Co Ltd |
腫瘍壊死因子産生阻害剤
|
GB9614238D0
(en)
|
1996-07-06 |
1996-09-04 |
Zeneca Ltd |
Chemical compounds
|
DE19630068A1
(de)
|
1996-07-25 |
1998-01-29 |
Basf Ag |
Neue flüssigkristalline Verbindungen und deren Vorprodukte
|
WO1998014450A1
(en)
|
1996-10-02 |
1998-04-09 |
Novartis Ag |
Pyrimidine derivatives and processes for the preparation thereof
|
DE59707681D1
(de)
*
|
1996-10-28 |
2002-08-14 |
Rolic Ag Zug |
Vernetzbare, photoaktive Silanderivate
|
ZA98376B
(en)
|
1997-01-23 |
1998-07-23 |
Hoffmann La Roche |
Sulfamide-metalloprotease inhibitors
|
KR100377696B1
(ko)
*
|
1997-01-23 |
2003-03-29 |
에프. 호프만-라 로슈 아게 |
설파미드-메탈로프로테아제 억제제
|
WO1999000386A1
(en)
|
1997-06-27 |
1999-01-07 |
Resolution Pharmaceuticals Inc. |
Dopamine d4 receptor ligands
|
CN1239570A
(zh)
|
1997-07-17 |
1999-12-22 |
索尼公司 |
磁记录介质和使用该介质的磁记录/再现装置
|
ES2125206B1
(es)
*
|
1997-07-21 |
1999-11-16 |
Esteve Labor Dr |
Derivados de acil-piperazinil-pirimidinas, su preparacion y su aplicacion como medicamentos.
|
SE9703377D0
(sv)
|
1997-09-18 |
1997-09-18 |
Astra Ab |
New compounds
|
AR013693A1
(es)
|
1997-10-23 |
2001-01-10 |
Uriach & Cia Sa J |
Nuevas piperidinas y piperazinas como inhibidores de la agregacion plaquetaria
|
WO1999021834A1
(en)
|
1997-10-27 |
1999-05-06 |
Neurosearch A/S |
Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
|
EP1048652A4
(en)
|
1997-12-26 |
2001-05-09 |
Mochida Pharm Co Ltd |
AROMATIC COMPOUNDS WITH A CYCLIC AMINO GROUP OR THEIR SALTS
|
DK1054874T3
(da)
|
1998-02-13 |
2002-12-30 |
Upjohn Co |
Substituerede aminophenylisoxazolinderivater, der er anvendelige som antimokrobielle midler
|
JP2002504550A
(ja)
|
1998-02-25 |
2002-02-12 |
ファルマシア・アンド・アップジョン・カンパニー |
抗微生物剤として有用な置換アミノメチルイソオキサゾリン誘導体
|
DE69904576T2
(de)
|
1998-03-19 |
2003-07-10 |
Upjohn Co |
Zur behandlung von cmv infektionen geeignete 1,3,4-thiadiazole
|
CN1297441A
(zh)
|
1998-04-20 |
2001-05-30 |
Basf公司 |
用作为钙蛋白酶抑制剂的杂环取代酰胺
|
WO1999055675A1
(de)
|
1998-04-29 |
1999-11-04 |
Axiva Gmbh |
Verfahren zur katalytischen herstellung von substituierten bipyridylderivaten
|
US6617339B1
(en)
|
1998-06-05 |
2003-09-09 |
Syngenta Limited |
Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
|
GB9812019D0
(en)
|
1998-06-05 |
1998-07-29 |
Zeneca Ltd |
Chemical compounds
|
ATE259803T1
(de)
|
1998-10-09 |
2004-03-15 |
Janssen Pharmaceutica Nv |
4,5-dehydroisoxazole derivate und ihre pharmazeutische verwendung
|
ATE256128T1
(de)
|
1998-10-21 |
2003-12-15 |
Takeda Chemical Industries Ltd |
Kondensierte pyridazinderivate, verfahren zu ihrer herstellung und ihre anwendung
|
EP1126833A4
(en)
|
1998-10-29 |
2004-09-08 |
Trega Biosciences Inc |
OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES CONTAINING THESE DERIVATIVES
|
EP1135129A1
(en)
|
1998-12-02 |
2001-09-26 |
Novo Nordisk A/S |
Use of n-substituted azaheterocyclic compounds for the manufacture of a pharmaceutical composition for the treatment of indications related to angiogenesis
|
GB9826412D0
(en)
|
1998-12-03 |
1999-01-27 |
Glaxo Group Ltd |
Chemical compounds
|
EP1156045A4
(en)
|
1999-01-28 |
2002-04-17 |
Nippon Shinyaku Co Ltd |
AMID DERIVATIVES AND DRUG COMPOSITIONS
|
WO2000044755A1
(en)
|
1999-01-29 |
2000-08-03 |
Abbott Laboratories |
Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
|
AU4166400A
(en)
|
1999-02-11 |
2000-08-29 |
Cor Therapeutics, Inc. |
Alkenyl and alkynyl compounds as inhibitors of factor xa
|
ATE277905T1
(de)
|
1999-02-24 |
2004-10-15 |
Hoffmann La Roche |
4-phenylpyridinderivate und deren verwendung als nk-1 rezeptorantagonisten
|
EP1165516B1
(en)
|
1999-03-12 |
2004-10-06 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Heterocyclic urea and related compounds useful as anti-inflammatory agents
|
AU779550B2
(en)
|
1999-04-09 |
2005-01-27 |
Meiji Seika Kaisha Ltd. |
Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same
|
FR2792314B1
(fr)
*
|
1999-04-15 |
2001-06-01 |
Adir |
Nouveaux composes aminotriazoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
RU2150700C1
(ru)
*
|
1999-04-27 |
2000-06-10 |
Волчек Игорь Владимирович |
Способ скрининга лекарственных препаратов
|
WO2000066578A1
(en)
|
1999-04-30 |
2000-11-09 |
Pfizer Products Inc. |
Compounds for the treatment of obesity
|
DE19922723A1
(de)
|
1999-05-18 |
2000-11-23 |
Clariant Gmbh |
Aktivmatrix-Displays mit hohem Kontrast
|
AU5020400A
(en)
|
1999-05-20 |
2000-12-12 |
E.I. Du Pont De Nemours And Company |
Heteroaryloxypyrimidine insecticides and acaricides
|
AU6000900A
(en)
|
1999-07-23 |
2001-02-13 |
Astrazeneca Uk Limited |
Carbazole derivatives and their use as neuropeptide y5 receptor ligands
|
DE19934799B4
(de)
*
|
1999-07-28 |
2008-01-24 |
Az Electronic Materials (Germany) Gmbh |
Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten
|
US6127382A
(en)
*
|
1999-08-16 |
2000-10-03 |
Allergan Sales, Inc. |
Amines substituted with a tetrahydroquinolinyl group an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
JP2003508509A
(ja)
|
1999-09-04 |
2003-03-04 |
アストラゼネカ アクチボラグ |
ピルビン酸デヒドロゲナーゼの阻害剤としてのアミド
|
AUPQ288499A0
(en)
|
1999-09-16 |
1999-10-07 |
Biota Scientific Management Pty Ltd |
Antiviral agents
|
TR200201413T2
(tr)
|
1999-09-17 |
2003-02-21 |
Millennium Pharmaceuticals, Inc. |
Faktör Xa' nın inhibitörleri.
|
EE04991B1
(et)
|
1999-09-24 |
2008-04-15 |
Janssen Pharmaceutica N.V. |
Osake, ravimvorm, nende valmistamismeetodid, osakeste kasutamine ning farmatseutiline pakend
|
US6677452B1
(en)
|
1999-09-30 |
2004-01-13 |
Lion Bioscience Ag |
Pyridine carboxamide or sulfonamide derivatives and combinatorial libraries thereof
|
WO2001032628A1
(en)
|
1999-11-03 |
2001-05-10 |
Bristol-Myers Squibb Pharma Company |
Cyano compounds as factor xa inhibitors
|
WO2001043746A1
(fr)
|
1999-12-14 |
2001-06-21 |
Nippon Shinyaku Co., Ltd. |
Composition medicinale
|
SE9904652D0
(sv)
|
1999-12-17 |
1999-12-17 |
Astra Pharma Prod |
Novel Compounds
|
DE60043397D1
(de)
|
1999-12-28 |
2010-01-07 |
Pharmacopeia Inc |
Cytokine, insbesondere tnf-alpha, hemmer
|
WO2001060458A2
(en)
|
2000-02-18 |
2001-08-23 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
WO2001060369A1
(en)
|
2000-02-18 |
2001-08-23 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
EP1315831B8
(en)
|
2000-02-24 |
2010-09-01 |
Xenon Pharmaceuticals Inc. |
Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
|
YU63802A
(sh)
|
2000-02-25 |
2005-06-10 |
F. Hoffmann-La Roche Ag. |
Modulatori adenozinskih receptora
|
AU2001245401A1
(en)
|
2000-03-01 |
2001-09-12 |
Sumitomo Pharmaceuticals Company, Limited |
Hydrazones and analogs as cholesterol lowering agents
|
CA2403017A1
(en)
|
2000-03-15 |
2001-09-20 |
Warner-Lambert Company |
5-amide substituted diarylamines as mex inhibitors
|
EP1339702A1
(en)
*
|
2000-03-15 |
2003-09-03 |
Warner-Lambert Company |
5-amide substituted diarylamines as mek inhibitors
|
US6613917B1
(en)
|
2000-03-23 |
2003-09-02 |
Allergan, Inc. |
Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
US20020045613A1
(en)
*
|
2000-04-27 |
2002-04-18 |
Heinz Pauls |
1-aroyl-piperidinyl benzamidines
|
MXPA02010693A
(es)
|
2000-04-28 |
2003-03-10 |
Tanabe Seiyaku Co |
Compuestos ciclicos.
|
BR0110428A
(pt)
|
2000-04-28 |
2003-06-17 |
Sankyo Co |
Composto ou um seu sal farmacologicamente aceitável, composição farmacêutica, usos de um composto ou um seu sal farmacologicamente aceitável, de um modulador de ppar gama e de um antagonista parcial, agentes que inibe a diferenciação de adipócitos, que acentua ou recupera a função osteogênica, para tratamento ou prevenção de osteoporose, que tem atividade moduladora de ppar gama, diminuidor do açúcar no sangue, para tratamento ou prevenção de diabetes melito, e, para tratamento ou prevenção
|
GB0010757D0
(en)
*
|
2000-05-05 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
GB0013378D0
(en)
|
2000-06-01 |
2000-07-26 |
Glaxo Group Ltd |
Use of therapeutic benzamide derivatives
|
GB0013383D0
(en)
|
2000-06-01 |
2000-07-26 |
Glaxo Group Ltd |
Therapeutic benzamide derivatives
|
GB0030304D0
(en)
|
2000-12-13 |
2001-01-24 |
Lilly Co Eli |
Compounds
|
EP1307444B1
(en)
*
|
2000-07-27 |
2007-10-03 |
Eli Lilly And Company |
Substituted heterocyclic amides
|
ATE284886T1
(de)
*
|
2000-08-08 |
2005-01-15 |
Sanofi Aventis |
Benzimidazolderivate, ihre herstellung und therapeutische verwendung
|
EP1184442A1
(en)
|
2000-08-30 |
2002-03-06 |
Clariant International Ltd. |
Liquid crystal mixture
|
DE60134995D1
(de)
|
2000-09-26 |
2008-09-04 |
Xenon Pharmaceuticals Inc |
Verfahren und zusammensetzungen, die eine stearoyl-coa desuturase-hscd5 verwenden
|
EP1322610A2
(en)
|
2000-09-29 |
2003-07-02 |
Millennium Pharmaceuticals, Inc. |
PIPERAZINE BASED INHIBITORS OF FACTOR Xa
|
FR2815032B1
(fr)
|
2000-10-10 |
2003-08-08 |
Pf Medicament |
Nouveaux derives d'aminophenyle piperazine ou d'amino phenyle piperide inhibiteurs de proteines prenyl transferase ainsi que leurs preparations
|
AU2001295436B2
(en)
|
2000-10-13 |
2006-07-20 |
Neurosearch A/S |
Novel azabicyclooctene derivatives and their medical use
|
JP4170753B2
(ja)
|
2000-10-17 |
2008-10-22 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
オキサゾリジノン化合物の製造方法
|
DE10060412A1
(de)
*
|
2000-12-05 |
2002-06-06 |
Bayer Ag |
DELTA1-Pyrroline
|
US7129242B2
(en)
|
2000-12-06 |
2006-10-31 |
Signal Pharmaceuticals, Llc |
Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
|
EP1351936A1
(en)
*
|
2001-01-15 |
2003-10-15 |
Glaxo Group Limited |
Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
|
NZ535574A
(en)
|
2001-01-16 |
2006-07-28 |
Astrazeneca Ab |
Therapeutic heterocyclic compounds
|
MXPA03006268A
(es)
|
2001-01-16 |
2003-09-22 |
Astrazeneca Ab |
Compuestos terapeuticos de cromano.
|
JP4280068B2
(ja)
|
2001-01-16 |
2009-06-17 |
アストラゼネカ・アクチエボラーグ |
治療用クロマン化合物
|
WO2002066446A1
(en)
|
2001-02-16 |
2002-08-29 |
Aventis Pharmaceuticals Inc. |
Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
|
WO2002070512A1
(fr)
|
2001-03-07 |
2002-09-12 |
Daiichi Pharmaceutical Co, Ltd. |
Procede de fabrication d'un derive d'azetidinone-2
|
US20020169166A1
(en)
|
2001-03-09 |
2002-11-14 |
Cowart Marlon D. |
Benzimidazoles that are useful in treating sexual dysfunction
|
AU2002336273A1
(en)
|
2001-03-09 |
2002-09-24 |
Ortho-Mcneil Pharmaceutical, Inc. |
Heterocyclic compounds and their use as histamine h4 ligands.
|
SE0100902D0
(sv)
|
2001-03-15 |
2001-03-15 |
Astrazeneca Ab |
Compounds
|
WO2002074750A1
(en)
*
|
2001-03-15 |
2002-09-26 |
Astrazeneca Ab |
Metalloproteinase inhibitors
|
FR2823209B1
(fr)
|
2001-04-04 |
2003-12-12 |
Fournier Lab Sa |
Nouvelles thiohydantoines et leur utilisation en therapeutique
|
US20040106794A1
(en)
|
2001-04-16 |
2004-06-03 |
Schering Corporation |
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
|
IL158262A0
(en)
|
2001-04-16 |
2004-05-12 |
Schering Corp |
3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
|
US6911447B2
(en)
*
|
2001-04-25 |
2005-06-28 |
The Procter & Gamble Company |
Melanocortin receptor ligands
|
US20050009834A1
(en)
|
2001-05-09 |
2005-01-13 |
Shigeyuki Itoh |
Azole compounds, process for preparation of the same and use thereof
|
EP1763350B1
(en)
|
2004-07-06 |
2011-12-21 |
Xenon Pharmaceuticals Inc. |
Nicotinamide derivatives and their use as therapeutic agents
|
CA2448298A1
(en)
|
2001-06-15 |
2002-12-27 |
Yamanouchi Pharmaceutical Co., Ltd. |
Phenylpyridine carbonyl piperazine derivative
|
US7115607B2
(en)
*
|
2001-07-25 |
2006-10-03 |
Amgen Inc. |
Substituted piperazinyl amides and methods of use
|
JO3429B1
(ar)
|
2001-08-13 |
2019-10-20 |
Janssen Pharmaceutica Nv |
مشتقات برميدينات مثبطة فيروس الايدز
|
US20030176437A1
(en)
|
2001-08-31 |
2003-09-18 |
D.M. Watterson |
Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
|
WO2003022274A2
(en)
|
2001-09-13 |
2003-03-20 |
Synta Pharmaceuticals Corp. |
2-aroylimidazole compounds for treating cancer
|
FR2829926B1
(fr)
*
|
2001-09-26 |
2004-10-01 |
Oreal |
Composition pour la teinture des fibres keratiniques comprenant un colorant diazoique dicationique particulier
|
US6916812B2
(en)
*
|
2001-10-09 |
2005-07-12 |
Bristol-Myers Squibb Company |
Alpha-aminoamide derivatives as melanocortin agonists
|
US6824707B2
(en)
*
|
2001-10-23 |
2004-11-30 |
Clariant International Ltd. |
Active matrix liquid crystal device and smectic liquid crystal mixture
|
WO2003035602A1
(fr)
|
2001-10-25 |
2003-05-01 |
Sankyo Company, Limited |
Modulateurs lipidiques
|
WO2003037862A1
(fr)
|
2001-10-30 |
2003-05-08 |
Nippon Shinyaku Co., Ltd. |
Derives amide, et medicaments correspondants
|
SE0103648D0
(sv)
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic quinolone compounds
|
SE0103649D0
(sv)
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic quinoline compounds
|
GB0127008D0
(en)
|
2001-11-09 |
2002-01-02 |
Novartis Ag |
Organic compounds
|
US6620811B2
(en)
|
2001-11-19 |
2003-09-16 |
Hoffmann-La Roche Inc. |
Isonicotin- and nicotinamide derivatives of benzothiazoles
|
WO2003045921A1
(en)
|
2001-11-28 |
2003-06-05 |
Fujisawa Pharmaceutical Co., Ltd. |
Heterocyclic amide compounds as apolipoprotein b inhibitors
|
CA2469228A1
(en)
|
2001-12-03 |
2003-06-12 |
Japan Tobacco Inc. |
Azole compound and medicinal use thereof
|
FR2833261B1
(fr)
|
2001-12-06 |
2004-07-02 |
Yang Ji Chemical Company Ltd |
Nouveaux composes inhibiteurs specifiques de la phospholipase a2 secretee non pancreatique humaine du groupe ii
|
EP1456175A1
(en)
|
2001-12-07 |
2004-09-15 |
Eli Lilly And Company |
Substituted heterocyclic carboxamides with antithrombotic activity
|
US6806279B2
(en)
|
2001-12-17 |
2004-10-19 |
Sunesis Pharmaceuticals, Inc. |
Small-molecule inhibitors of interleukin-2
|
US20050119251A1
(en)
*
|
2001-12-21 |
2005-06-02 |
Jian-Min Fu |
Nicotinamide derivatives and their use as therapeutic agents
|
US20030166932A1
(en)
*
|
2002-01-04 |
2003-09-04 |
Beard Richard L. |
Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
PL372390A1
(en)
|
2002-02-05 |
2005-07-25 |
Novo Nordisk A/S |
Novel aryl- and heteroarylpiperazines
|
OA12789A
(en)
|
2002-03-13 |
2006-07-10 |
Janssen Pharmaceutica Nv |
Carbonylamino-derivatives as novel inhibitors of histone deacetylase.
|
BR0307624A
(pt)
|
2002-03-13 |
2005-01-11 |
Janssen Pharmaceutica Nv |
Inibidores de histona desacetilase
|
AU2003218738B2
(en)
|
2002-03-13 |
2009-01-08 |
Janssen Pharmaceutica N.V. |
Sulfonyl-derivatives as novel inhibitors of histone deacetylase
|
DK1485354T3
(da)
|
2002-03-13 |
2008-09-01 |
Janssen Pharmaceutica Nv |
Sulfonylamino-derivater som nye inhibitorer af histandeacetylase
|
AR038966A1
(es)
|
2002-03-18 |
2005-02-02 |
Solvay Pharm Bv |
Derivados de tiazol que tienen actividad antagonista, agonista o agonista parcial de cb1
|
AU2003220184A1
(en)
|
2002-03-20 |
2003-10-08 |
Schering Aktiengesellschaft |
Substituted piperazine antithrombotic pai-1 inhibitors
|
DE10217006A1
(de)
|
2002-04-16 |
2003-11-06 |
Merck Patent Gmbh |
Substituierte Indole
|
US7119203B2
(en)
|
2002-04-25 |
2006-10-10 |
Pharmacia Corporation |
Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
|
GB0209715D0
(en)
|
2002-04-27 |
2002-06-05 |
Astrazeneca Ab |
Chemical compounds
|
US6982259B2
(en)
|
2002-04-30 |
2006-01-03 |
Schering Aktiengesellschaft |
N-heterocyclic derivatives as NOS inhibitors
|
HUP0202001A2
(hu)
|
2002-06-14 |
2005-08-29 |
Sanofi-Aventis |
DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok
|
WO2004000820A2
(en)
|
2002-06-21 |
2003-12-31 |
Cellular Genomics, Inc. |
Certain aromatic monocycles as kinase modulators
|
WO2004000318A2
(en)
|
2002-06-21 |
2003-12-31 |
Cellular Genomics, Inc. |
Certain amino-substituted monocycles as kinase modulators
|
WO2004009587A1
(en)
|
2002-07-22 |
2004-01-29 |
Orchid Chemicals & Pharmaceuticals Ltd |
Oxazolidinone derivatives as antibacterial agents
|
CA2493584A1
(en)
|
2002-07-25 |
2004-02-05 |
Wisconsin Alumni Research Foundation |
Inhibition of stearoyl-coa desaturase 1 (scd1) increases insulin sensitivity and treats diabetes
|
TW200413377A
(en)
|
2002-09-04 |
2004-08-01 |
Schering Corp |
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
JP2006503827A
(ja)
|
2002-09-06 |
2006-02-02 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
アレルギー性鼻炎治療用薬剤を製造する目的でインドリル誘導体を用いる使用
|
CA2499429C
(en)
|
2002-09-18 |
2010-09-21 |
Pfizer Products Inc. |
Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors
|
AP2005003262A0
(en)
|
2002-09-18 |
2005-03-31 |
Pfizer Prod Inc |
Novel isothiazole and isoxazole compounds as tranforming growth factor (TGF) inhibitors.
|
JP2006505570A
(ja)
|
2002-10-17 |
2006-02-16 |
アムジエン・インコーポレーテツド |
ベンズイミダゾール誘導体およびそれのバニロイド受容体リガンドとしての使用
|
DE10250708A1
(de)
|
2002-10-31 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
US20040097492A1
(en)
*
|
2002-11-01 |
2004-05-20 |
Pratt John K |
Anti-infective agents
|
FR2847253B1
(fr)
|
2002-11-19 |
2007-05-18 |
Aventis Pharma Sa |
Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant
|
DE10254875A1
(de)
|
2002-11-25 |
2004-06-03 |
Bayer Healthcare Ag |
Phenylsulfoxid und -sulfon-Derivate
|
JP2004203871A
(ja)
|
2002-12-13 |
2004-07-22 |
Yamanouchi Pharmaceut Co Ltd |
医薬組成物
|
DE10259382A1
(de)
|
2002-12-18 |
2004-07-01 |
Abbott Gmbh & Co. Kg |
3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-4-on-Derivate, ihre Herstellung und Verwendung
|
WO2004058727A1
(en)
|
2002-12-20 |
2004-07-15 |
Bayer Pharmaceuticals Corporation |
Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
|
ATE374766T1
(de)
|
2003-01-14 |
2007-10-15 |
Arena Pharm Inc |
1,2,3-trisubstituierte aryl- und heteroarylderivate als modulatoren des metabolismus zur vorbeugung und behandlung von metabolismus-bedingten krankheiten wie diabetes oder hyperglykämie
|
WO2004065378A1
(en)
|
2003-01-17 |
2004-08-05 |
Warner-Lambert Company Llc |
2-aminopyridine substituted heterocycles as inhibitors of cellular proliferation
|
US20050130989A1
(en)
*
|
2003-01-28 |
2005-06-16 |
Aventis Pharma S. A. |
N-arylheteroaromatic products compositions containing them and use thereof
|
EP1603883B1
(en)
|
2003-02-03 |
2012-03-28 |
Janssen Pharmaceutica NV |
Quinoline-derived amide modulators of vanilloid vr1 receptor
|
GB0302671D0
(en)
|
2003-02-06 |
2003-03-12 |
Astrazeneca Ab |
Pharmaceutical formulations
|
PL227577B1
(pl)
|
2003-02-07 |
2017-12-29 |
Janssen Pharmaceutica Nv |
Zastosowanie pochodnych pirymidyny do wytwarzania leku do zapobiegania zakażeniu wirusem HIV oraz kompozycja farmaceutyczna
|
MXPA05008368A
(es)
|
2003-02-07 |
2005-11-04 |
Janssen Pharmaceutica Nv |
1,2,4-triazinas inhibidoras del virus de inmunodeficiencia humana.
|
DE10306250A1
(de)
*
|
2003-02-14 |
2004-09-09 |
Aventis Pharma Deutschland Gmbh |
Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US7223788B2
(en)
*
|
2003-02-14 |
2007-05-29 |
Sanofi-Aventis Deutschland Gmbh |
Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
|
EP1594842A1
(en)
|
2003-02-22 |
2005-11-16 |
MERCK PATENT GmbH |
Cyanopyridone derivatives as liquid crystals
|
ES2316964T3
(es)
|
2003-02-24 |
2009-04-16 |
Arena Pharmaceuticals, Inc. |
Fenil-y piridilpipereidinia-derivados como moduladores del metabolismo de la glucosa.
|
US6861422B2
(en)
*
|
2003-02-26 |
2005-03-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
US7160886B2
(en)
|
2003-03-03 |
2007-01-09 |
Merck & Co., Inc. |
Acylated piperazine derivatives as melanocortin-4 receptor agonists
|
WO2004089416A2
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
Combination of an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent
|
DE602004021585D1
(de)
|
2003-04-29 |
2009-07-30 |
Pfizer Ltd |
5,7-DIAMINOPYRAZOLOi4,3-D PYRIMIDINE ZUR VERWENDUNG IN DER BEHANDLUNG VON BLUTHOCHDRUCK
|
SE0301369D0
(sv)
*
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Chemical compounds
|
JP4847868B2
(ja)
|
2003-05-14 |
2011-12-28 |
ニューロジェネティック ファーマシューティカルズ、 インコーポレイテッド |
化合物、及び、アミロイドベータの調節におけるその使用
|
DE10322408A1
(de)
|
2003-05-16 |
2004-12-02 |
Degussa Ag |
Stickstoffhaltige monodentate Phosphine und deren Verwendung in der Katalyse
|
GB0312832D0
(en)
|
2003-06-04 |
2003-07-09 |
Pfizer Ltd |
2-amino-pyridine derivatives useful for the treatment of diseases
|
AR044586A1
(es)
*
|
2003-06-04 |
2005-09-21 |
Aventis Pharma Sa |
Productos aril - heteroaromaticos, composiciones que los contienen y su utilizacion
|
WO2005003087A2
(en)
|
2003-07-01 |
2005-01-13 |
Orchid Chemicals And Pharmaceuticals Ltd. |
Oxazole derivatives as antibacterial agents
|
JP2007526894A
(ja)
|
2003-07-16 |
2007-09-20 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
グリコーゲンシンターゼキナーゼ3インヒビターとしてのトリアゾロピリミジン誘導体
|
BRPI0412596A
(pt)
|
2003-07-16 |
2006-09-19 |
Janssen Pharmaceutica Nv |
derivados de triazolopirimidina como inibores de glicogênio sintase cinase 3
|
US20070161637A1
(en)
|
2003-07-22 |
2007-07-12 |
Neurogen Corporation |
Substituted pyridin-2-ylamine analogues
|
FR2857966A1
(fr)
*
|
2003-07-24 |
2005-01-28 |
Aventis Pharma Sa |
Produits aryl-heteroaromatiques, compositions les contenant et utilisation
|
AR045134A1
(es)
|
2003-07-29 |
2005-10-19 |
Smithkline Beecham Plc |
Compuesto de 1h - imidazo [4,5-c] piridin-ilo, composicion farmaceutica que lo comprende, proceso para prepararla, su uso para preparar dicha composicion farmaceutica, combinacion farmaceutica, uso de la combinacion farmaceutica para la preparacion de un medicamento, procedimientos para preparar dic
|
RU2006101452A
(ru)
|
2003-07-29 |
2006-06-27 |
Ново Нордиск А/С (DK) |
Пиридазинил-пиперазины и их применение в качестве лигандов h3 гистаминового рецептора
|
US7763618B2
(en)
|
2003-07-29 |
2010-07-27 |
Xenon Pharmaceuticals Inc. |
Pyridyl derivatives and their use as therapeutic agents
|
ES2386353T3
(es)
|
2003-07-30 |
2012-08-17 |
Xenon Pharmaceuticals Inc. |
Derivados de piridazina y su uso como agentes terapéuticos
|
EP1648874B1
(en)
*
|
2003-07-30 |
2011-10-05 |
Xenon Pharmaceuticals Inc. |
Piperazine derivatives and their use as therapeutic agents
|
CA2533901A1
(en)
|
2003-07-30 |
2005-02-10 |
Xenon Pharmaceuticals Inc. |
Piperazine derivatives and their use as therapeutic agents
|
US7754711B2
(en)
*
|
2003-07-30 |
2010-07-13 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives and their use as therapeutic agents
|
AU2004261267B9
(en)
|
2003-07-30 |
2009-04-09 |
Xenon Pharmaceuticals Inc. |
Pyridyl derivatives and their use as therapeutic agents
|
WO2005014563A1
(en)
|
2003-08-11 |
2005-02-17 |
F. Hoffmann-La Roche Ag |
Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors
|
JP4866610B2
(ja)
|
2003-08-18 |
2012-02-01 |
富士フイルムファインケミカルズ株式会社 |
ピリジルテトラヒドロピリジン類およびピリジルピペリジン類
|
NZ545715A
(en)
|
2003-08-25 |
2009-02-28 |
Adenosine Therapeutics Llc |
Substituted 8-heteroaryl xanthines
|
US20070082908A1
(en)
*
|
2003-08-29 |
2007-04-12 |
Dainippon Sumitomo Pharma Co., Ltd. |
Bicycle pyrazole derivative
|
BRPI0413536B8
(pt)
*
|
2003-09-09 |
2021-05-25 |
Hoffmann La Roche |
derivados de 1-benzoil-piperazina, seu uso e medicamento que os compreende
|
KR100774630B1
(ko)
|
2003-09-09 |
2007-11-08 |
에프. 호프만-라 로슈 아게 |
정신병의 치료를 위한 글라이신 섭취 억제제로서의1-(2-아미노-벤졸)-피페라진 유도체
|
US20050065178A1
(en)
|
2003-09-19 |
2005-03-24 |
Anwer Basha |
Substituted diazabicycloakane derivatives
|
US7399765B2
(en)
*
|
2003-09-19 |
2008-07-15 |
Abbott Laboratories |
Substituted diazabicycloalkane derivatives
|
DE602004031641D1
(de)
|
2003-09-25 |
2011-04-14 |
Janssen Pharmaceutica Nv |
Die replikation von hiv hemmende purinderivate
|
AR047759A1
(es)
|
2003-09-26 |
2006-02-22 |
Vertex Pharma |
Derivados de fenil - piperazina como moduladores de receptores muscarnicos
|
CA2537812C
(en)
|
2003-09-26 |
2013-01-22 |
Exelixis, Inc. |
C-met modulators and method of use
|
US7199149B2
(en)
|
2003-10-01 |
2007-04-03 |
Bristol Myers Squibb Company |
Monocyclic and bicyclic lactams as factor Xa inhibitors
|
US7807696B2
(en)
|
2003-10-07 |
2010-10-05 |
The Feinstein Institute For Medical Research |
Isoxazole and isothiazole compounds useful in the treatment of inflammation
|
FR2860793A1
(fr)
|
2003-10-14 |
2005-04-15 |
Entomed |
Composes derives de norcantharidine, leurs procedes de preparation, les compositions les contenant et leurs utilisations
|
US20050124625A1
(en)
|
2003-10-21 |
2005-06-09 |
Salvati Mark E. |
Piperazine derivatives and their use as modulators of nuclear hormone receptor function
|
US20050192286A1
(en)
|
2003-10-22 |
2005-09-01 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
EP1753413A2
(en)
|
2003-10-24 |
2007-02-21 |
Solvay Pharmaceuticals GmbH |
Novel medical uses of compounds showing cb sb 1/sb -antagonistic activity and combination treatment involving said compounds
|
US20050124660A1
(en)
*
|
2003-10-27 |
2005-06-09 |
Jochen Antel |
Novel medical uses of compounds showing CB1-antagonistic activity and combination treatment involving said compounds
|
WO2005044192A2
(en)
|
2003-10-28 |
2005-05-19 |
Amgen Inc. |
Triazole compounds and uses related thereto
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
GB0327319D0
(en)
|
2003-11-24 |
2003-12-24 |
Pfizer Ltd |
Novel pharmaceuticals
|
GB0327323D0
(en)
|
2003-11-24 |
2003-12-31 |
Pfizer Ltd |
Novel pharmaceuticals
|
OA13338A
(en)
|
2003-12-18 |
2007-04-13 |
Incyte Corp |
3-cycloalkylaminopyrrolidine derivates as modulators of chemokine receptors.
|
KR100854872B1
(ko)
|
2003-12-22 |
2008-08-28 |
화이자 인코포레이티드 |
바소프레신 길항제로서의 트리아졸 유도체
|
US7345043B2
(en)
*
|
2004-04-01 |
2008-03-18 |
Miikana Therapeutics |
Inhibitors of histone deacetylase
|
AR048523A1
(es)
*
|
2004-04-07 |
2006-05-03 |
Kalypsys Inc |
Compuestos con estructura de aril sulfonamida y sulfonilo como moduladores de ppar y metodos para tratar trastornos metabolicos
|
TW200626572A
(en)
*
|
2004-09-20 |
2006-08-01 |
Xenon Pharmaceuticals Inc |
Heterocyclic derivatives and their use as therapeutic agents
|
BRPI0515505A
(pt)
*
|
2004-09-20 |
2008-07-29 |
Xenon Pharmaceuticals Inc |
derivados heterocìclicos e sua utilização como inibidores da estearoil-coa desaturase
|
EP2316457A1
(en)
*
|
2004-09-20 |
2011-05-04 |
Xenon Pharmaceuticals Inc. |
Pyridine derivatives for inhibiting human stearoyl-coa-desaturase
|
CA2580781A1
(en)
*
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coa-desaturase (scd)
|
AR051202A1
(es)
|
2004-09-20 |
2006-12-27 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
|
AR051094A1
(es)
|
2004-09-20 |
2006-12-20 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
|
AU2005286846A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as therapeutic agents
|
EP1804799B1
(en)
|
2004-09-20 |
2013-08-21 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
|
BRPI0515483A
(pt)
|
2004-09-20 |
2008-07-22 |
Xenon Pharmaceuticals Inc |
derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase
|
WO2006106423A2
(en)
|
2005-04-07 |
2006-10-12 |
Pfizer Inc. |
Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
|
EP2540296A1
(en)
|
2005-06-03 |
2013-01-02 |
Xenon Pharmaceuticals Inc. |
Arminothiazole derivatives as human stearoyl-coa desaturase inhibitors
|
AU2006255465A1
(en)
|
2005-06-09 |
2006-12-14 |
Merck Frosst Canada Ltd |
Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|